These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 33928831)

  • 41. Comparison of different mesoporous silicas for off-line solid phase extraction of 17β-estradiol from waters and its determination by HPLC-DAD.
    Gañán J; Pérez-Quintanilla D; Morante-Zarcero S; Sierra I
    J Hazard Mater; 2013 Sep; 260():609-17. PubMed ID: 23827729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sustained release of heparin on enlarged-pore and functionalized MCM-41.
    Wan MM; Yang JY; Qiu Y; Zhou Y; Guan CX; Hou Q; Lin WG; Zhu JH
    ACS Appl Mater Interfaces; 2012 Aug; 4(8):4113-22. PubMed ID: 22850329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation and characterization of electrospun silica nanofibers from PVP/P123 blended polymer solution.
    Roh SH; Lee YA; Lee JW; Kim SI
    J Nanosci Nanotechnol; 2008 Oct; 8(10):5147-51. PubMed ID: 19198409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effective controlled release of captopril by silylation of mesoporous MCM-41.
    Qu F; Zhu G; Huang S; Li S; Qiu S
    Chemphyschem; 2006 Feb; 7(2):400-6. PubMed ID: 16411260
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z; Gong H; Liu M; Zhu H; Sun H
    J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delivery of [Ru(η
    Edeler D; Arlt S; Petković V; Ludwig G; Drača D; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
    J Inorg Biochem; 2018 Mar; 180():155-162. PubMed ID: 29288894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imidazolium-based ionic liquid functionalized mesoporous silica nanoparticles as a promising nano-carrier: response surface strategy to investigate and optimize loading and release process for Lapatinib delivery.
    Peyvand P; Vaezi Z; Sedghi M; Dalir N; Ma'mani L; Naderi-Manesh H
    Pharm Dev Technol; 2020 Nov; 25(9):1150-1161. PubMed ID: 32746669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Eu3+, Tb3+/β-diketonate functionalized mesoporous SBA-15/GaN composites: multi-component chemical bonding assembly, characterization, and luminescence.
    Zhao Y; Yan B
    J Colloid Interface Sci; 2013 Apr; 395():145-53. PubMed ID: 23374434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enlarged Pore Size Chiral Mesoporous Silica Nanoparticles Loaded Poorly Water-Soluble Drug Perform Superior Delivery Effect.
    Guo Y; Gou K; Yang B; Wang Y; Pu X; Li S; Li H
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31575047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization and release kinetics study of potato starch nanocomposite films containing mesoporous nano-silica incorporated with Thyme essential oil.
    Cui Y; Cheng M; Han M; Zhang R; Wang X
    Int J Biol Macromol; 2021 Aug; 184():566-573. PubMed ID: 34174300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Improving the dissolution rate of poorly water-soluble resveratrol by the ordered mesoporous silica].
    Quan GL; Chen B; Wang ZH; Wu H; Huang XT; Wu LN; Wu CB
    Yao Xue Xue Bao; 2012 Feb; 47(2):239-43. PubMed ID: 22512038
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
    Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies.
    Sapino S; Ugazio E; Gastaldi L; Miletto I; Berlier G; Zonari D; Oliaro-Bosso S
    Eur J Pharm Biopharm; 2015 Jan; 89():116-25. PubMed ID: 25478737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and characterization of surface modified SBA-15 silica materials and their application in chromatography.
    Yasmin T; Müller K
    J Chromatogr A; 2011 Sep; 1218(37):6464-75. PubMed ID: 21835411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surface-Activated Fibre-Like SBA-15 as Drug Carriers for Bone Diseases.
    Prokopowicz M; Żeglinski J; Szewczyk A; Skwira A; Walker G
    AAPS PharmSciTech; 2018 Dec; 20(1):17. PubMed ID: 30574669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dodecylamine Template-Based Hexagonal Mesoporous Silica (HMS) as a Carrier for Improved Oral Delivery of Fenofibrate.
    Jadhav NV; Vavia PR
    AAPS PharmSciTech; 2017 Oct; 18(7):2764-2773. PubMed ID: 28353172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An ion-imprinted imidazole-functionalized ordered mesoporous silica for selective removal of chromium(VI) from electroplating effluents.
    Cen S; Yang L; Li R; Gong S; Tan J; Zeng L
    Environ Sci Pollut Res Int; 2022 Jul; 29(31):47516-47526. PubMed ID: 35182346
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adsorption properties of proteins on SBA-15 nanoparticles functionalized with aminosilanes.
    Lee JW; Tra PT; Kim SI; Roh SH
    J Nanosci Nanotechnol; 2008 Oct; 8(10):5152-7. PubMed ID: 19198410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modification of SBA-15 mesoporous silica as an active heterogeneous catalyst for the hydroisomerization and hydrocracking of n-heptane.
    Ali NS; Alismaeel ZT; Majdi HS; Salih HG; Abdulrahman MA; Cata Saady NM; Albayati TM
    Heliyon; 2022 Jun; 8(6):e09737. PubMed ID: 35756106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.